RC Medical is a medical device venture studio that funds, designs, develops, and commercializes products for the interventional radiology market, and its chief executive says the company's defining feature is that it starts in the clinical setting rather than with an engineer's concept. "We go to the interventional suite first," David Ferrera says. "The physicians there see the gaps every week. Our job is to listen, then build the company around what they're actually describing." The distinction matters because most medical device companies begin with an engineering idea and then search for a clinical problem to fit it, a sequence that can produce technology in search of a use.
Rather than taking on contract work for outside clients, RC Medical partners directly with physician-entrepreneurs to identify new technology and new indications for devices, then forms a standalone company to carry each idea forward. Ferrera describes the physician relationship as a partnership that runs from the first sketch through commercialization. "A physician knows the problem better than anyone," he says. "What we bring is the engineering, the regulatory path, and the discipline to turn that problem into something that can actually reach patients. Neither side can do it alone." The physician stays close to the clinical need while RC Medical manages product development, funding, and the business structure needed to commercialize it.
When an idea clears the studio's early bar, RC Medical does not fold it into an existing product line. It forms a new company around it. "Each idea gets its own company, its own team, its own focus," Ferrera says. "A big portfolio company can lose a good idea in the shuffle. A newco can't afford to." That approach has produced three separate companies out of the studio: Single Pass, Infinity Neuro, and Sonorous NV. Each one grew out of a specific problem a physician described in the interventional suite, and each operates as its own business rather than a product line inside RC Medical.
Ferrera has spent close to three decades building devices for interventional neuroradiology and related fields, including his time as a co-founder of Blockade Medical and as Chief Technology Officer of Balt Global. He says the lesson that carries over to RC Medical is that physicians in these procedures see problems that never make it into a traditional product roadmap. "A catheter that works in a textbook case can still fail in the specific anatomy a physician sees three times a week," he says. "That detail doesn't show up unless you're building with the physician, not for them." The studio model is built to catch that detail early, before a device design is locked in and hard to change.
Ferrera says the studio is not the right fit for every idea and that he does not present it that way to the physicians who bring one in. "Some ideas are better as a feature of an existing product, not a new company," he says. "Part of the first conversation is being honest about which one this is." For the ideas that do become a newco, the physician's involvement does not end once the company is formed. Many stay close to the product as it moves through development and toward the market, which keeps the clinical need in view at every stage rather than only at the start. The implication for interventional radiology is a development structure that treats physician-observed procedural gaps as the starting point for company formation, potentially shortening the distance between an unmet clinical need and a commercial device.
